Catalyst
Slingshot members are tracking this event:
Roche's (RHHBY) Tecentriq Approved by FDA for Advanced Bladder Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
RHHBY |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tecentriq, Fda, Advanced Bladder Cancer, Approval